Modern methods of pharmacovigilance: Detecting adverse effects of drugs

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 5, 2009, Pages 486-489

  Norén, G Niklas ^a   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

Adverse drug reaction; Cohort event monitoring; Individual case safety report; Longitudinal electronic patient records

Indexed keywords

ABACAVIR; INFLIXIMAB; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ANTICHOLINERGIC SYNDROME; BLEEDING; CLINICAL PHARMACOLOGY; COHORT ANALYSIS; CONVULSION; DRUG EFFICACY; DRUG INFORMATION; DRUG PROGRAM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; GLAUCOMA; HEART INFARCTION; HUMAN; LONGITUDINAL STUDY; MEDICATION ERROR; PERICARDIAL EFFUSION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; QUANTITATIVE ANALYSIS; REVIEW; UNITED KINGDOM; VASCULITIS;

EID: 72849116877     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-5-486     Document Type: Review

References (22)

1. Finney DJ. Monitoring adverse reactions to drugs - its logic and its weaknesses. Proc Eur Soc Study Drug Toxicol 1966;7:198-207.
2. Evans SJ. Pharmacovigilance: a science or fielding emergencies? Stat Med 2000;19:3199-3209
3. Edwards IR. Spontaneous reporting - of what? Clinical concerns about drugs. Br J Clin Pharmacol 1999;48:138-141
4. Meyboom RH, Egberts AC, Edwards IR et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997;16:355-365
5. Aronson JK, Hauben M. Anecdotes that provide definitive evidence. BMJ 2006;333:1267-1269 (Pubitemid 46032359)
6. Edwards IR, Lindquist M, Wiholm BE, Napke E. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990;336:156-158 (Pubitemid 20224982)
7. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001;134:330-334
8. Clarke A, Deeks JJ, Shakir SA. An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf 2006;29:175-181 (Pubitemid 43213891)
9. Bate A, Lindquist M, Edwards IR et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998;54:315-321 (Pubitemid 28328016)
10. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001;10:483-486 (Pubitemid 34100774)
11. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System. Am Stat 1999;53:177-190
12. Egberts AC, Meyboom RH, van Puijenbroek E. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002;25:453-458
13. Norén GN, Sundberg R, Bate A, Edwards IR. A statistical methodology for drug-drug interaction surveillance. Stat Med 2008;27:3057-3070
14. Norén GN, Orre R, Bate A, Edwards IR. Duplicate detection in adverse drug reaction surveillance. Data Min Knowl Disc 2007;14:305-328 (Pubitemid 46582604)
15. Ståhl M, Lindquist M, Edwards IR, Brown EG. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoepidemiol Drug Saf 2004;13:355-363 (Pubitemid 38787154)
16. Coulter DM. The New Zealand Intensive Medicines Monitoring Programme. Pharmacoepidemiol Drug Saf 1998;7:79-90.
17. Mann RD. Prescription-event monitoring - recent progress and future horizons. Br J Clin Pharmacol 1998;46:195-201.
18. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004;27:871-881 (Pubitemid 39331685)
19. Brown JS, Kulldorff M, Chan KA et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007;16:1275-1284 (Pubitemid 350303439)
20. Norén GN, Bate A, Hopstadius J, Star K, Edwards IR. Temporal pattern discovery for trends and transient effects: its application to patient records. In: Proceeding of the 14th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 24-27 August 2008, Las Vegas, Nevada, USA.
21. Hocine MN, Musonda P, Andrews NJ, Farrington C. Sequential case series analysis for pharmacovigilance. J R Stat Soc Ser A (Statistics in Society) 2009;172:213-236
22. Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003;327:1222-1225 (Pubitemid 37465212)